// App-Quantinova.ai

: Is N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) disturbed in polycystic ovary syndrome?

Researchers

Presenter

  • Malgorzata Kaluzna

Principal Investigators

  • Pola Kompf

  • Katarzyna Ziemnicka

  • Krauze Tomasz

  • Katarzyna Wachowiak-Ochmanska

  • Andrzej Wykretowicz

  • Przemyslaw Guzik

  • Marek Ruchala

Medical Centers

  • Poznan Univeristy of Medical Sciences, Department of Endocrinology, Metabolism and Internal Diseases

  • Poznan Univeristy of Medical Sciences, Department of Cardiology - Intensive Therapy, Poland

  • Heliodor Swiecicki University Hospital, Endocrinology, Metabolism and Internal Diseases Ward, Poland

Locations

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Obstetrics/Gynecology

Disease

  • Polycystic Ovary Syndrome

  • Hypertension

Biomarkers

  • B-type natriuretic peptide

  • N-terminal pro b-type natriuretic peptide

Drug/Treatment

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Observational

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved